US equities
|
META
$642.62
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
NVDA
$210.96
▲+0.00%
NU
$15.16
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
META
$642.62
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
NVDA
$210.96
▲+0.00%
NU
$15.16
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:GALT
Recent news which mentions NASDAQ:GALT
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
August 13, 2024
Tickers
GALT
Tags
NASDAQ:GALT
Earnings Reports
Market News
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
May 15, 2024
Tickers
GALT
Tags
GALT
Market News
Earnings Reports
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
April 05, 2024
Tickers
GALT
Tags
NASDAQ:GALT
Earnings Reports
Market News
From
InvestorPlace
Is Galectin Therapeutics a Good Cancer Stock to Own?
July 16, 2021
Tags
NASDAQ:GALT
From
StockNews.com